Simsen News & Stories
How Pharma Companies Can Leverage Simsen Diagnostic’s Tumour-Informed ctDNA Analysis to Transform Cancer Drug Trials
Developing effective cancer treatments is one of the most challenging frontiers in drug development, where ...
Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025
Simsen Diagnostics is excited to announce our participation in the upcoming GoCo Investor Day, a leading ...
Simsen Diagnostics' hospital laboratory solution
We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative ...
Simsen Diagnostics to Attend Ecosystem Exchange: Life Sciences 2025
We are pleased to announce that our CEO, Pontus Rehn, will represent Simsen Diagnostics at the upcoming ...
Simsen will attend the Swiss Nordic Bio 2025
Simsen Diagnostics is excited to announce its participation in the upcoming Swiss Nordic Bio 2025 conference, ...
Simsen announces collaboration with Buzzard Pharmaceuticals
Gothenburg, 21 February 2025 Simsen Diagnostics Partners with Buzzard Pharmaceuticals for Isunakinra ...
Simsen Diagnostics Announces Collaboration with Private Cancer Center Docrates
Gothenburg 2024-10-25: Simsen Diagnostics has signed an agreement with Docrates, a private cancer center in ...
Interview with Ola Nilsson, Neogap Therapeutics
A few weeks ago, we had the opportunity to meet with Ola Nilsson, Head of Neoantigen Production & ...
Mid-Year Summary 2024
As we approach summer and vacations (at least for some of us in the office and most industry people here in ...
Simsen Diagnostics and Orion Corporation Announce Collaboration for Phase I Study
Gothenburg, 2024-06-26 – Simsen Diagnostics is announcing a new exciting collaboration with Orion ...
Simsen Diagnostics Awarded Vinnova Grant for FIRM Liquid Biopsy Project
Gothenburg 2024-04-23 – Simsen Diagnostics announces having received a Vinnova grant through the strategic ...